Join our new Cancer Alliance Bulletin to:

  • Learn about the latest pathway improvement initiatives in pancreatic cancer, including the Optimal Care Pathway for pancreatic cancer
  • Hear about how we at Pancreatic Cancer UK can support you to implement improvements in pancreatic cancer locally
  • Read case studies and examples of where areas have implemented improvements in pancreatic cancer pathways – to help you make similar changes locally
  • Get updates on our wider work that’s relevant to you as a cancer alliance, such as our health professional educational events and online courses

This bi-monthly bulletin is exclusively for cancer alliances in England. If you work for a cancer alliance, please complete the form below to join the bulletin:

Address*
Female Doctor giving medication to a male patient

Optimal Care Pathway Hub

A UK-wide guide to implement better and fairer standards of care for people with pancreatic cancer through an optimal care pathway

Read more
Nurse talking to older female patient in a hospital bed

Health professionals

Resources for health professionals to help you provide the best possible care for your patients 

Read more

Early diagnosis

Late diagnosis is one of the biggest issues in pancreatic cancer but we’re investing in ground-breaking research to change this 

Read more
  • Driving Treatment Breakthroughs in Westminster

    Driving Treatment Breakthroughs in Westminster

    On 16th June, we hosted a parliamentary reception in Westminster, calling on Government to take urgent action to drive treatment breakthroughs for pan...

  • Insights from people newly diagnosed

    Insights from people newly diagnosed

    We welcome the commitment in the National Cancer Plan to establish direct referral pathways over the coming years, ensuring that people newly diagnose...

  • Just 12% of pancreatic cancer patients given the chance to join a clinical trial

    Just 12% of pancreatic cancer patients given the chance to join a clinical trial

    Only 12% of people with pancreatic cancer are given the chance to take part in a clinical trial, emphasising the lack of progress in developing treatm...